Chagas cardiomyopathy: Europe is not spared!

European Heart Journal

Volumn 29, Issue 21, 2008, Pages 2587-2591

  Guerri Guttenberg, Roberto A ^a   Grana, Daniel R ^a   Ambrosio, Giuseppe ^b   Milei, José ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHAGAS DISEASE; CLINICAL FEATURE; EUROPE; HUMAN; IMMIGRANT; INCIDENCE; LIFE EXPECTANCY; NONHUMAN; NOTE; PARASITE TRANSMISSION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; TRYPANOSOMA CRUZI;

CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; EMIGRATION AND IMMIGRATION; EUROPE; HUMANS; INCIDENCE; PREVALENCE;

EID: 55749104084     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehn424     Document Type: Note

References (25)

1. Milei J, Guerri-Guttenberg RA, Azzato F, Storino RA. Chagasic cardiomyopathy: new trends for an old burden. Cardiomyopathies: Causes, Effects and Treatment. Hauppauge, New York: Nova Science Publishers; 2008, in press.
2. Storino RA, Milei J. Enfermedad de Chagas. Mosby-Doyma: Buenos Aires; 1994.
3. Leiby DA, Herron RMJ, Garratty G, Herwaldt BL. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008; [Epub ahead of print].
4. Milei J, Fernandez-Alonso G, Vanzulli S, Storino RA, Maturri L, Rossi L. Myocardial inflammatory infiltrate in human chronic Chagasic cardiomyopathy: immunohistochemical findings. Cardiovasc Pathol 1996;5:209-219.
5. Milei J, Mautner B, Storino RA, Sanchez JA, Ferrans VJ. Does Chagas' disease exist as an undiagnosed form of cardiomyopathy in the United States? Am Heart J 1992;123:1732-1735.
6. Jones EM, Colley DG, Tostes S, Reis-Lopez E, Vnencak-Jones CL, McCurley TL. Amplification of Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 1993;48:348-357.
7. Marin-Neto JA, Rassi A, Morillo C, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 2008;156:37-43.
8. Storino RA, Milei J, Beigelman R, Ferrans VJ. Enfermedad de Chagas: doce años de seguimiento en área urbana. Rev Argent Cardiol 1992;60:205-216.
9. Theodoropoulos TAD, Bestetti RB, Ottaviano AP, Cordeiro JA, Rodrigues VC, Silva AC. Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy. Int J Cardiol 2008;128:22-29.
10. Pellegrino A. Migration from Latin America to Europe: Trends and Policy Challenges. Uruguay: International Organization for Migration (IOM); 2004.
11. CELADE. Migración internacional de latinoamericanos y caribeños en iberoamérica: Características, retos y oportunidades. Encuentro Iberoamericano sobre Migración y Desarrollo. Madrid; 2006.
12. Schmunis G. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007;102:75-85.
13. Zeledón R, Solano G, Burstin L, Swartzwelder J. Epidemiological pattern of Chagas' disease in an endemic area of Costa Rica. Am J Trop Med Hyg 1975;24:214-225.
14. Basquiera A, Sembaj A, Aguerri A, Omelianiuk MSG, Moreno Barral J, Caeiro T, Madoery R, Salomone O. Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 2003;89:1186-1190.
15. Lescure FX, Canestri A, Melliez H, Jauréguiberry S, Develoux M, Dorent R, Guiard-Schmid JB, Bonnard P, Ajana F, Rolla V, Carlier Y, Gay F, Elghouzzi MH, Danis M, Pialoux G. Chagas disease in France. Emerg Infect Dis 2008;14:644-646.
16. Riera C, Guarro A, Kassab HE, Jorba JM, Castro M, Angrill R, Gállego M, Fisa R, Martin C, Lobato A, Portús M. Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am J Trop Med Hyg 2006;75:1078-1081.
17. Pihl T, Strand EA, Strand O, Ohm O. Chagas disease in Norway. Tidsskr Nor Laegeforen 2007;127:1820-1823.
18. Florián-Sanz F, Gómez-Navarro C, Castrillo-García N, Pedrote-Martínez A, Lage-Gallé E. Chagasic cardiomyopathy in Spain: a diagnosis to bear in mind. Ann Med Intern 2005;22:538- 540.
19. Enemark H, Seibaek M, Kirchhoff LV, Jensen G. Chronic Chagas disease - an echo from youth. Ueskr Laeger 2000;162:2567-2569.
20. Muñoz J, Portús M, Corachan M, Fumadó V, Gascon J. Congenital Trypanosoma cruzi infection in non-endemic area. Trans R Soc Trop Med Hyg 2007;101:1161-1162.
21. Sztajzel J, Cox J, Pache JC, Badaoui E, Lerch R, Rutishauser W. Chagas' disease may also be encountered in Europe. Eur Heart J 1996;17:1289.
22. Frank M, Hegenscheid B, Janitschke K, Weinke T. Prevalence and epidemiological significance of trypanosoma cruzi infection among Latin American immigrants in Berlin, Germany. Infection 1997;25:355-358.
23. Gascón J, Albajar P, Cañas E, Flores M, Gómez i Prat J, Herrera RN, Lafuente CA, Luciardi HL, Moncayo A, Molina L, Muñoz J, Puente S, Sanz G, Treviño B, Sergio Salles X. Diagnosis, management, and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic. Rev Esp Cardiol 2007;60:285-293.
24. Amorin DS, Manco JC, Gallo L, Marin Neto JA. Clínica: Forma Cardíaca. In: Brener Z, Andrade Z, eds. Trypanosoma cruzi e Doenca de Chagas. Rio de Janeiro: Guanabara Koogan, 1979 p265-311.
25. Pondé A. A cardiopatía crónica na molestias de Chagas. Hospital (Rio de Janeiro) 1960;6:58.